SCHEMBL4880642

SCHEMBL4880642

CCOc1cccc(C2(CNS(=O)(=O)NC(=O)O)CCC(NCc3ccc(-c4ccccc4)cc3)CC2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
RAB9A P51151 1/20 0.38
PTGER2 P43116 2/20 0.37
RXRA P19793 1/20 0.37
RXRB P28702 1/20 0.37
HDAC1 Q13547 2/20 0.36
OPRM1 P35372 2/20 0.36
OPRL1 P41146 2/20 0.36
MMP2 P08253 2/20 0.36
MMP1 P03956 1/20 0.36
MMP3 P08254 1/20 0.36
MMP13 P45452 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SLC13A5 Q86YT5 1/20 0.35
TACR1 P25103 1/20 0.34
SLC2A1 P11166 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4880630 1.00 KDM4E (0.38) KDM4EALDH1A1TDP1KMT2AMEN1
SCHEMBL4871944 0.92 MMP1 (0.42) ALDH1A1KMT2AMEN1RAB9AHDAC1
SCHEMBL4871938 0.92 MMP1 (0.42) ALDH1A1KMT2AMEN1RAB9AHDAC1
SCHEMBL4878196 0.92 MMP1 (0.42) ALDH1A1KMT2AMEN1RAB9AHDAC1
SCHEMBL4879294 0.89 MEN1 (0.41) KDM4EALDH1A1TDP1KMT2AMEN1
SCHEMBL4879286 0.89 MEN1 (0.41) KDM4EALDH1A1TDP1KMT2AMEN1
Hydrochloric Acid SCHEMBL4880396 0.87 MEN1 (0.42) KDM4EALDH1A1TDP1KMT2AMEN1
Hydrochloric Acid SCHEMBL4880381 0.87 MEN1 (0.42) KDM4EALDH1A1TDP1KMT2AMEN1
SCHEMBL4872172 0.86 MMP1 (0.42) ALDH1A1KMT2AMEN1RAB9AHDAC1
SCHEMBL4872167 0.86 MMP1 (0.42) ALDH1A1KMT2AMEN1RAB9AHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096922-A1 Novel Sulfonamide derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-04-24 US disclosed
EP-1736467-A1 NOVEL SULFONAMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2006-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096922-A1 Novel Sulfonamide derivative NR4A1, NR4A2, NR4A3 KDM4E 768/4885ALDH1A1 2899/4885TDP1 4445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.